BCSF
Bain Capital Specialty Finance, Inc.
BCSF trails on the overall score without a compensating advantage in the available component scores.
JPM
JPMorgan Chase & Co.
JPM has the edge over BCSF overall, supported by stronger valuation and stronger fundamentals.
BCSF Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| N/A | |
| N/A |
BCSF's profitability is currently healthy, but its revenue is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like BCSF.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
BCSF PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.3x | $7.02 | -37% |
| Forward | 8.1x | $11.06 | — |
| Fair | 8.5x | $8.15 | -26% |
| Expensive | 10x | $9.56 | -14% |
| Current | 12x | $11.06 | — |
Historical ranges are pointers, not guarantees.
BCSF's PE is in its expensive range at 12x. On analysts' estimates for next year's earnings, today's price would be 8.1x, in its cheap range.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over BCSF in the historical PE scenario, which offers more potential upside but is not a forecast.
BCSF Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong decline | |
| Decline | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect BCSF's earnings and revenue to decline, with profitability weakening. However, they disagree widely on these estimates.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
BCSF Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.37 | +43% |
| Q3 2026 | $0.96 | -33% |
| Q2 2026 | $0.99 | -40% |
| Q1 2026 | $1.14 | -34% |
| Q4 2025 | $1.53 | -17% |
| Q3 2025 | $1.44 | -28% |
| Q2 2025 | $1.66 | -17% |
| Q1 2025 | $1.74 | -13% |
| Q4 2024 | $1.85 | -2.6% |
BCSF's earnings per share have fallen from their peak: $0.96 over the past year, against $2.56 in mid-2021.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over BCSF on earnings, with more consistent year-over-year improvement.
BCSF Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2022 | $30.4M | -40% |
| Q1 2022 | $46.3M | +5.3% |
| Q4 2021 | $40.7M | -22% |
| Q3 2021 | $40.4M | -41% |
| Q2 2021 | $50.3M | +23% |
| Q4 2020 | $52.5M | +27% |
JPM has the stronger quarterly revenue trend. Revenue is down 40% for BCSF versus up 8.1% for JPM.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2022 | 57% | -28 points |
| Q1 2022 | 73% | +0.5 points |
| Q4 2021 | 55% | -21 points |
| Q3 2021 | 58% | -18 points |
| Q2 2021 | 84% | +31 points |
| Q1 2021 | 72% | N/A |
| Q4 2020 | 76% | +24 points |
| Q3 2020 | 76% | N/A |
BCSF's operating margin was 57% last quarter, down 28 points from the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
BCSF Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $137.9M | +1433% |
| Q2 2026 | $70.8M | +10858% |
| Q1 2026 | $26.6M | +$33.9M |
| Q4 2025 | $27.2M | +$47.1M |
| Q3 2025 | $9M | +$144.8M |
| Q2 2025 | $646K | -100% |
| Q1 2025 | -$7.3M | +$56.4M |
| Q4 2024 | -$20M | -107% |
BCSF has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
BCSF Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | 0% | -- |
| 3 years | +0.5% | +306K shares |
| 5 years | +0.5% | +306K shares |
| Available history | +26% | +13.2M shares |
BCSF has 65M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over BCSF on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
BCSF Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2022 | 12.4x | High |
| Q1 2022 | 8.3x | High |
| Q4 2021 | 10.8x | High |
| Q3 2021 | 9.6x | High |
| Q2 2021 | 7.7x | High |
| Q1 2021 | 9.0x | High |
| Q4 2020 | 165.0x | High |
| Q4 2019 | 10.6x | High |
BCSF's net debt is about 12 years of its operating earnings (EBITDA), up from 7.7 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BCSF.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
BCSF Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.0 | Neutral |
| Stochastic | 31.3 | Neutral |
BCSF's weekly RSI is 41 (neutral) and its Stochastic is 31 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
BCSF PE vs Financial Services Sector
| Metric | BCSF | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 12% below |
| PE % | 93 | 63 | 30 pts above |
BCSF has the edge over JPM on valuation relative to its sector.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
BCSF Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.8 | 2.8% above |
| 20 week MA | $11.7 | 5.1% below |
| 50 week MA | $12.6 | 12% below |
| 100 week MA | $14.2 | 22% below |
| 200 week MA | $14.7 | 25% below |
BCSF has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 25% below its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over BCSF on trend strength, trading above more of its moving averages.
BCSF Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $20.2 | $12.4 | -38% |
| 2021 | $12.4 | $15.6 | +25% |
| 2022 | $15.6 | $12.5 | -19% |
| 2023 | $12.5 | $15.1 | +20% |
| 2024 | $15.1 | $17.7 | +17% |
| 2025 | $17.7 | $13.9 | -21% |
| 2026 YTD | $13.9 | $11.1 | -21% |
BCSF has finished lower in three of the last six years. It's down 21% so far in 2026.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over BCSF on returns for 2026, with the stronger performance.